These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9535824)

  • 1. Lactacystin, proteasome function, and cell fate.
    Fenteany G; Schreiber SL
    J Biol Chem; 1998 Apr; 273(15):8545-8. PubMed ID: 9535824
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.
    Fenteany G; Standaert RF; Lane WS; Choi S; Corey EJ; Schreiber SL
    Science; 1995 May; 268(5211):726-31. PubMed ID: 7732382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone.
    Dick LR; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Stein RL
    J Biol Chem; 1996 Mar; 271(13):7273-6. PubMed ID: 8631740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitinylation and proteasome-dependent degradation of the phosphoinositide-specific phospholipase C gamma 1 in A-431 cells.
    Evdonin AL; Tsupkina NV; Nikol'skii NN; Medvedeva ND
    Dokl Biol Sci; 2003; 392():456-7. PubMed ID: 14650885
    [No Abstract]   [Full Text] [Related]  

  • 5. Lactacystin augments the sulindac-induced apoptosis in HT-29 cells.
    Choi HJ; Kim HH; Lee HS; Huh GY; Seo SY; Jeong JH; Kim JM; Yoo YH
    Apoptosis; 2003 Jun; 8(3):301-5. PubMed ID: 12766490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome-dependent degradation of oxidized proteins in MRC-5 fibroblasts.
    Sitte N; Merker K; Grune T
    FEBS Lett; 1998 Dec; 440(3):399-402. PubMed ID: 9872410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
    Wagenknecht B; Hermisson M; Eitel K; Weller M
    Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
    Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
    J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme.
    Ostrowska H; Wojcik C; Omura S; Worowski K
    Biochem Biophys Res Commun; 1997 May; 234(3):729-32. PubMed ID: 9175783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of proteasome in myogenic differentiation of murine myocytes and human rhabdomyosarcoma cells.
    Mugita N; Honda Y; Nakamura H; Fujiwara T; Tanaka K; Omura S; Shimbara N; Ogawa M; Saya H; Nakao M
    Int J Mol Med; 1999 Feb; 3(2):127-37. PubMed ID: 9917519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of proteasome to its inhibitors increases during cAMP-induced differentiation of neuroblastoma cells in culture and causes decreased viability.
    Kumar B; Hanson AJ; Prasad KN
    Cancer Lett; 2004 Feb; 204(1):53-9. PubMed ID: 14744534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactacystin increases LDL receptor level on HepG2 cells.
    Miura H; Tomoda H; Miura K; Takishima K; Omura S
    Biochem Biophys Res Commun; 1996 Oct; 227(3):684-7. PubMed ID: 8885994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells.
    Kudo Y; Takata T; Ogawa I; Kaneda T; Sato S; Takekoshi T; Zhao M; Miyauchi M; Nikai H
    Clin Cancer Res; 2000 Mar; 6(3):916-23. PubMed ID: 10741716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome activity is critical for the cAMP-induced differentiation of neuroblastoma cells.
    Nahreini P; Andreatta C; Prasad KN
    Cell Mol Neurobiol; 2001 Oct; 21(5):509-21. PubMed ID: 11860188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibitors block development of Plasmodium spp.
    Gantt SM; Myung JM; Briones MR; Li WD; Corey EJ; Omura S; Nussenzweig V; Sinnis P
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2731-8. PubMed ID: 9756786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells.
    Dick LR; Cruikshank AA; Destree AT; Grenier L; McCormack TA; Melandri FD; Nunes SL; Palombella VJ; Parent LA; Plamondon L; Stein RL
    J Biol Chem; 1997 Jan; 272(1):182-8. PubMed ID: 8995245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome activity is required for the stage-specific transformation of a protozoan parasite.
    González J; Ramalho-Pinto FJ; Frevert U; Ghiso J; Tomlinson S; Scharfstein J; Corey EJ; Nussenzweig V
    J Exp Med; 1996 Nov; 184(5):1909-18. PubMed ID: 8920878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.
    Ogiso Y; Tomida A; Lei S; Omura S; Tsuruo T
    Cancer Res; 2000 May; 60(9):2429-34. PubMed ID: 10811120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome pathway operates for the degradation of ornithine decarboxylase in intact cells.
    Murakami Y; Tanahashi N; Tanaka K; Omura S; Hayashi S
    Biochem J; 1996 Jul; 317 ( Pt 1)(Pt 1):77-80. PubMed ID: 8694789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
    Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
    J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.